ŌURA has attracted more than $900 million in funding led by Fidelity Management & Research Company with significant participation from new investor ICONIQ and contributions from Whale Rock and Atreides. The investment, valuing ŌURA at approximately $11 billion, will fuel continued growth and development of new health technologies.

ŌURA plans to use the new funding to accelerate artificial intelligence (AI) and product innovation, expand global distribution, and invest in development of new health features, cementing its position as a major proactive health platform. The latest financing reflects ŌURA’s momentum, following the company’s announcement that it has sold more than 5.5 million Oura Ring devices since its 2015 debut—with more than half of those sales occurring in the past year alone. The company reported more than $500 million in 2024 revenue, doubling its growth from the prior year, and is on track to double revenue again this year, surpassing $1 billion in annual sales while continuing to expand profitability.

“This new funding is a testament to the strength of ŌURA’s business and the trust millions of members place in us every day,” ŌURA CEO Tom Hale stated. “We’re proud to be building not just a product, but a global movement toward proactive health—helping people understand their bodies, make better lifestyle decisions, and connect more effectively with their healthcare providers. Today, our technology supports consumers, employers, insurers, and clinicians working together to advance preventive health at scale. With this investment, we will accelerate innovation, expand our global reach, and set a new standard for what wearables can achieve in advancing preventive health.”

As part of the company’s continued growth, ŌURA announced Lateralus Holdings Founder and nine-year ŌURA board member David Shuman as its new board chair to succeed Eurie Kim, who has been at the helm since 2019. “David has been a wonderful board partner to me during my tenure as chair and I look forward to continuing to collaborate with him as we help ŌURA reach its potential,” Kim said.

“Eurie and David have been instrumental in ŌURA’s success. Since joining the board in 2019, Eurie has been a trusted partner as we’ve rapidly grown our consumer awareness. I look forward to her continued guidance on the board through the company’s next phase of growth,” Hale added. “ŌURA has benefited greatly from David’s leadership and good judgement across long-term strategy, fundraising, recruiting, partnerships, and corporate development—and I know he’ll be instrumental in our continued success and growth as we enter our next chapter.”

The company will also expand its board of directors with the upcoming nomination of Wen Hsieh, founding managing partner at Matter Venture Partners. An electrical engineer by training, Hsieh has extensive hardtech investing and domain knowledge, having served as a managing partner at Kleiner Perkins and serving as board chairman at Ambiq Micro.

“ŌURA’s growth and impact over the past year have been truly remarkable,” Shuman commented. “The company has doubled revenue, expanded its global reach, and delivered transformative solutions that are reshaping the wearables industry. I am grateful to Eurie for her leadership and wise counsel through this period of incredible growth. I’m also thrilled for Wen’s upcoming nomination to the board. He brings a wealth of knowledge regarding battery technology, custom silicon, and intellectual property that will support ŌURA’s mission to make health a daily practice.”

The company recently introduced a major product expansion with Oura Ring 4 Ceramic in new colors as well as the company’s first hardware accessory, the Oura Ring 4 Charging Case, and Health Panels, a first-of-its-kind integration, which allows members to schedule and see the results of their lab tests directly in the Oura App. These launches underscore ŌURA’s expanding role as a platform for preventive health, supporting individuals, employers, and insurers through scalable, data-driven wellness solutions that connect everyday insights with long-term health outcomes.

ŌURA delivers personalized health data, insights, and daily guidance with Oura Ring, a smart ring that helps users live healthier, longer. Guided by a mission to shift healthcare from sick care to prevention, ŌURA supports millions of members worldwide across sleep, activity, stress, readiness, women’s health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring provides more than 50 health and wellness metrics and insights in addition to partner data, empowering both individuals and thousands of research teams, healthcare providers, and organizations. With 1,000-plus ecosystem partners across wellness and medicine, ŌURA is advancing the future of preventative health.

Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses. Founded in Finland in 2013 and headquartered in San Francisco, ŌURA has raised approximately $1.5 billion and was last valued at approximately $11 billion—making it the world’s most valuable standalone wearable company.